首页 > 最新文献

Journal of Obstetrics and Gynaecology Research最新文献

英文 中文
Maternal and neonatal outcomes of occiput posterior vaginal delivery 枕后阴道分娩的产妇和新生儿结局。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-29 DOI: 10.1111/jog.16174
Mizuho Sawai, Ryosuke Shindo, Sayuri Nakanishi, Soichiro Obata, Etsuko Miyagi, Shigeru Aoki

Aim

The occiput posterior (OP) position is the most common fetal malposition associated with poorer maternal outcomes compared to the occiput anterior (OA) position. However, there are no equivalent reports for women in Japan. This study aimed to investigate the maternal and neonatal outcomes of OP delivery in Japan.

Methods

This retrospective study was conducted at a tertiary hospital in Japan. Singleton pregnant women who delivered vaginally at and after 37 weeks of gestation between January 2000 and May 2023 were included. Participants were divided into OA and OP groups and pregnancy outcomes were compared. Multivariable analysis was performed to adjust for background.

Results

In total, 13 852 eligible participants were divided into OA (13 633, 98.4%) and OP (218, 1.6%) groups. Maternal weights were significantly higher in the OP group than in the OA group, but there were no significant differences in maternal age, height, BMI, and parity. The incidence of assisted vaginal delivery (6.0% vs. 25.2%, adjusted odds ratios [aOR] 6.97), third- or fourth-degree perineal laceration (0.9% vs. 2.8%, aOR 3.52), postpartum hemorrhage (4.3% vs. 8.7%, aOR 2.17), and prolonged second stage of labor (11.3% vs. 29.4%, aOR 4.75) were significantly higher in the OP group. On the other hand, there were no significant differences in neonatal outcomes.

Conclusion

The present study showed that OP vaginal deliveries require more time, and the increased number of assisted vaginal deliveries resulted in more maternal lacerations and hemorrhage. Maternal complications should be noted in the management of OP deliveries.

目的:与枕后位(OA)相比,枕后位(OP)是最常见的胎儿畸形位,与较差的产妇结局相关。然而,在日本没有针对女性的类似报告。本研究旨在调查日本OP分娩的产妇和新生儿结局。方法:在日本某三级医院进行回顾性研究。2000年1月至2023年5月期间在妊娠37周内及之后顺产的单胎孕妇被纳入研究范围。将参与者分为OA组和OP组,比较妊娠结局。进行多变量分析以调整背景。结果:共有13 852名符合条件的受试者被分为OA组(13 633人,98.4%)和OP组(218人,1.6%)。OP组的产妇体重明显高于OA组,但在年龄、身高、BMI和胎次方面没有显著差异。OP组辅助阴道分娩(6.0% vs. 25.2%,调整优势比[aOR] 6.97)、会阴三度或四度撕裂伤(0.9% vs. 2.8%, aOR 3.52)、产后出血(4.3% vs. 8.7%, aOR 2.17)和第二产程延长(11.3% vs. 29.4%, aOR 4.75)的发生率均显著高于OP组。另一方面,在新生儿结局方面没有显著差异。结论:本研究表明,OP阴道分娩需要更多的时间,并且辅助阴道分娩次数的增加导致更多的产妇撕裂和出血。在OP分娩管理中应注意产妇并发症。
{"title":"Maternal and neonatal outcomes of occiput posterior vaginal delivery","authors":"Mizuho Sawai,&nbsp;Ryosuke Shindo,&nbsp;Sayuri Nakanishi,&nbsp;Soichiro Obata,&nbsp;Etsuko Miyagi,&nbsp;Shigeru Aoki","doi":"10.1111/jog.16174","DOIUrl":"10.1111/jog.16174","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The occiput posterior (OP) position is the most common fetal malposition associated with poorer maternal outcomes compared to the occiput anterior (OA) position. However, there are no equivalent reports for women in Japan. This study aimed to investigate the maternal and neonatal outcomes of OP delivery in Japan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective study was conducted at a tertiary hospital in Japan. Singleton pregnant women who delivered vaginally at and after 37 weeks of gestation between January 2000 and May 2023 were included. Participants were divided into OA and OP groups and pregnancy outcomes were compared. Multivariable analysis was performed to adjust for background.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In total, 13 852 eligible participants were divided into OA (13 633, 98.4%) and OP (218, 1.6%) groups. Maternal weights were significantly higher in the OP group than in the OA group, but there were no significant differences in maternal age, height, BMI, and parity. The incidence of assisted vaginal delivery (6.0% vs. 25.2%, adjusted odds ratios [aOR] 6.97), third- or fourth-degree perineal laceration (0.9% vs. 2.8%, aOR 3.52), postpartum hemorrhage (4.3% vs. 8.7%, aOR 2.17), and prolonged second stage of labor (11.3% vs. 29.4%, aOR 4.75) were significantly higher in the OP group. On the other hand, there were no significant differences in neonatal outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The present study showed that OP vaginal deliveries require more time, and the increased number of assisted vaginal deliveries resulted in more maternal lacerations and hemorrhage. Maternal complications should be noted in the management of OP deliveries.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A wake-up call: Pakistan under-5 mortality rate trails its neighbors 警钟长鸣:巴基斯坦 5 岁以下儿童死亡率落后于邻国。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-28 DOI: 10.1111/jog.16167
Usman Muhammad Ahsan, Hasham Ahmed, Umar Farooq
{"title":"A wake-up call: Pakistan under-5 mortality rate trails its neighbors","authors":"Usman Muhammad Ahsan,&nbsp;Hasham Ahmed,&nbsp;Umar Farooq","doi":"10.1111/jog.16167","DOIUrl":"10.1111/jog.16167","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of dysmenorrhea changes in patients undergoing cervical dilatation: Does it work? 评估宫颈扩张术患者痛经的变化:它有用吗?
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-28 DOI: 10.1111/jog.16170
Ilkhan Keskin, Osman Samet Günkaya, Arzu Bilge Tekin, Murat Yassa, Niyazi Tuğ

Objective

To demonstrate that cervical dilation will relieve symptoms in women with primary dysmenorrhea.

Materials and Methods

In this retrospective cohort study, 30 patients were included in the study group and 30 patients were included in the control group. Age, sex, occupation, education level, duration of dysmenorrhea, and presence of dyspareunia were recorded for all patients. Dilation and hysteroscopy were performed on indicated patients in the study group. In both groups, pain and dysmenorrhea levels were assessed preoperatively and at 1 and 2 months postoperatively using the “Visual Analog Score,” “Facial Pain Scale,” “Quality of Life Questionnaire,” and “Quality of Life Questionnaire Health Status Scale.”

Results

There were no statistically significant differences in the results of VAS, Facial Pain Scale, Quality of Life Questionnaire, Quality of Life Questionnaire Health Status Scale before the procedure between the two groups (MWU(Z) = −0.354, p: 0.753), (MWU(Z) = −1.680, p: 0.093), (MWU(Z) = −0.787, p: 0.431), (MWU(Z) = −1.557, p: 0.119, respectively). Although there were no statistically significant differences in the control group survey scores in the second survey, the scores in all surveys in the study group were statistically significant (p < .05).

Conclusion

This study shows that the complaints of the patients decrease in the short and medium term after cervical dilatation.

目的:证明宫颈扩张术可缓解原发性痛经妇女的症状:证明宫颈扩张术可缓解原发性痛经妇女的症状:在这项回顾性队列研究中,30 名患者被纳入研究组,30 名患者被纳入对照组。所有患者的年龄、性别、职业、教育程度、痛经持续时间和是否存在排便困难均记录在案。对研究组中的指定患者进行了扩宫和宫腔镜检查。使用 "视觉模拟评分"、"面部疼痛量表"、"生活质量问卷 "和 "生活质量问卷健康状况量表 "对两组患者术前、术后1个月和2个月的疼痛和痛经程度进行评估:两组术前的 "视觉模拟评分"、"面部疼痛量表"、"生活质量问卷"、"生活质量问卷健康状况量表 "结果差异无统计学意义(MWU(Z)=-0.354,P:0.753)、(MWU(Z)=-1.680,P:0.093)、(MWU(Z)=-0.787,P:0.431)、(MWU(Z)=-1.557,P:0.119)。虽然在第二次调查中,对照组的调查得分在统计学上没有显著差异,但研究组的所有调查得分在统计学上都有显著差异(P 结论:研究组的调查得分在统计学上没有显著差异:本研究表明,宫颈扩张术后患者的主诉在短期和中期内会减少。
{"title":"Evaluation of dysmenorrhea changes in patients undergoing cervical dilatation: Does it work?","authors":"Ilkhan Keskin,&nbsp;Osman Samet Günkaya,&nbsp;Arzu Bilge Tekin,&nbsp;Murat Yassa,&nbsp;Niyazi Tuğ","doi":"10.1111/jog.16170","DOIUrl":"10.1111/jog.16170","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To demonstrate that cervical dilation will relieve symptoms in women with primary dysmenorrhea.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>In this retrospective cohort study, 30 patients were included in the study group and 30 patients were included in the control group. Age, sex, occupation, education level, duration of dysmenorrhea, and presence of dyspareunia were recorded for all patients. Dilation and hysteroscopy were performed on indicated patients in the study group. In both groups, pain and dysmenorrhea levels were assessed preoperatively and at 1 and 2 months postoperatively using the “Visual Analog Score,” “Facial Pain Scale,” “Quality of Life Questionnaire,” and “Quality of Life Questionnaire Health Status Scale.”</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were no statistically significant differences in the results of VAS, Facial Pain Scale, Quality of Life Questionnaire, Quality of Life Questionnaire Health Status Scale before the procedure between the two groups (MWU(Z) = −0.354, <i>p</i>: 0.753), (MWU(Z) = −1.680, <i>p</i>: 0.093), (MWU(Z) = −0.787, <i>p</i>: 0.431), (MWU(Z) = −1.557, <i>p</i>: 0.119, respectively). Although there were no statistically significant differences in the control group survey scores in the second survey, the scores in all surveys in the study group were statistically significant (<i>p</i> &lt; .05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study shows that the complaints of the patients decrease in the short and medium term after cervical dilatation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remnant ureter abscess linked to obstructed hemivagina and ipsilateral renal anomaly syndrome 输尿管残余脓肿与半阴道梗阻和同侧肾脏异常综合征有关。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-28 DOI: 10.1111/jog.16171
Meika Kaneko, Hiroshi Ishikawa, Takaoki Kaneko, Asuka Sato, Makio Shozu, Kaori Koga

Patients with obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome sometimes present with distinct symptoms related to coexisting urogenital abnormalities. We present a case of refractory abscess formation in a blind-ended remnant ureter associated with ipsilateral renal agenesis. A 15-year-old patient with OHVIRA syndrome, who had a blind-ended remnant ureter, underwent obstructed hemivagina opening 18 months after menarche due to heavy genital bleeding and abdominal pain after the end of menstruation. Four years later, the patient presented with recurring fever and abdominal pain due to a refractory abscess in the ureter. Although the continuity between the ureter and the previously opened hemivagina was not identified, the same bacteria were detected in the abscess and vaginal discharge, indicating that an ascending bacterial infection of the vagina may cause refractory abscess formation in a blind-ended remnant ureter. Open ureterectomy with partial bladder resection was needed to resolve the symptoms.

梗阻性半阴道和同侧肾脏异常(OHVIRA)综合征患者有时会出现与并存的泌尿生殖系统异常相关的不同症状。我们介绍了一例伴有同侧肾发育不全的盲端残余输尿管内难治性脓肿形成的病例。一名 15 岁的 OHVIRA 综合征患者患有盲端残余输尿管,在月经初潮后 18 个月,因大量生殖器出血和月经结束后腹痛而接受了梗阻性血尿开放手术。四年后,患者因输尿管内的难治性脓肿而反复出现发热和腹痛。虽然输尿管和之前打开的半阴道之间的连续性没有被确定,但在脓肿和阴道分泌物中检测到了相同的细菌,这表明阴道的上升型细菌感染可能会导致盲端残余输尿管形成难治性脓肿。需要进行开放性输尿管切除术和膀胱部分切除术才能缓解症状。
{"title":"Remnant ureter abscess linked to obstructed hemivagina and ipsilateral renal anomaly syndrome","authors":"Meika Kaneko,&nbsp;Hiroshi Ishikawa,&nbsp;Takaoki Kaneko,&nbsp;Asuka Sato,&nbsp;Makio Shozu,&nbsp;Kaori Koga","doi":"10.1111/jog.16171","DOIUrl":"10.1111/jog.16171","url":null,"abstract":"<p>Patients with obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome sometimes present with distinct symptoms related to coexisting urogenital abnormalities. We present a case of refractory abscess formation in a blind-ended remnant ureter associated with ipsilateral renal agenesis. A 15-year-old patient with OHVIRA syndrome, who had a blind-ended remnant ureter, underwent obstructed hemivagina opening 18 months after menarche due to heavy genital bleeding and abdominal pain after the end of menstruation. Four years later, the patient presented with recurring fever and abdominal pain due to a refractory abscess in the ureter. Although the continuity between the ureter and the previously opened hemivagina was not identified, the same bacteria were detected in the abscess and vaginal discharge, indicating that an ascending bacterial infection of the vagina may cause refractory abscess formation in a blind-ended remnant ureter. Open ureterectomy with partial bladder resection was needed to resolve the symptoms.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of expression of amino acid and fatty acid metabolic transporters in the placenta of pregnant women with glucose intolerance 评估葡萄糖不耐受孕妇胎盘中氨基酸和脂肪酸代谢转运体的表达。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-26 DOI: 10.1111/jog.16163
Toshihide Sakuragi, Eiji Shibata, Megumi Yamamoto, Shohei Shimajiri, Emi Kondo, Hiroshi Mori, Ryosuke Tajiri, Toshiyuki Nakayama, Kiyoshi Yoshino, Mayumi Tsuji

Aim

Pregnant women with glucose intolerance often have large infants, even with strict glycemic control. We examined the expression of amino and fatty acid metabolic transporters in the placentas of such mothers to clarify the role of factors other than glucose transport resulting in giant infants.

Methods

Deliveries at our hospital between 2017 and 2022 were assessed. Immunohistochemical staining of membrane transporters related to glucose, amino acid, and fatty acid transport was performed using postpartum placental tissue. Stained areas were classified and scored, and compared using the Mann–Whitney U test. Multiple logistic regression analysis was performed for large for gestational age infant as the outcome and maternal age, prepartum body mass index, primipara/multipara, gestational week, and glucose intolerance as confounding factors.

Results

Among 1725 subjects, 101 met the inclusion criteria and were analyzed (glucose-intolerant [GI] group, n = 61; non-GI group, n = 40). Per unit villus, there was decreased expression of amino acid-related transporters. However, per unit placenta, the immunohistochemical staining scores for glucose, amino acid, and fatty acid transport were significantly higher in the GI than in the non-GI group. Multiple logistic regression analysis showed that L-type amino acid transporter 1 (LAT1, odds ratio [95% confidence interval]: 12.35 [2.93–52.05], p < 0.001) and placenta-plasma membrane fatty acid-binding protein (placenta-FABPpm, 6.27 [1.64–23.88], p = 0.007) were significantly higher in the GI than in the non-GI group.

Conclusion

Activation of LAT1 and placenta-FABPpm expressions observed in the placentas of glucose-intolerant women despite glycemic control indicate that nutrients other than blood glucose should also be effectively managed.

目的:即使严格控制血糖,患有葡萄糖不耐受症的孕妇也经常会生下巨大儿。我们研究了此类母亲胎盘中氨基酸和脂肪酸代谢转运体的表达,以明确除葡萄糖转运外导致巨大儿的其他因素的作用:对我院2017年至2022年间的分娩情况进行评估。使用产后胎盘组织对与葡萄糖、氨基酸和脂肪酸转运相关的膜转运体进行免疫组化染色。对染色区域进行分类和评分,并使用 Mann-Whitney U 检验进行比较。以大胎龄婴儿为结果,以产妇年龄、产前体重指数、初产妇/多产妇、孕周和葡萄糖不耐受为混杂因素,进行多元逻辑回归分析:在 1725 名受试者中,101 人符合纳入标准并接受了分析(葡萄糖不耐受 [GI] 组,n = 61;非 GI 组,n = 40)。每单位绒毛中,氨基酸相关转运体的表达量减少。然而,就单位胎盘而言,糖耐量[GI]组的葡萄糖、氨基酸和脂肪酸转运的免疫组化染色评分明显高于非糖耐量[GI]组。多重逻辑回归分析表明,L 型氨基酸转运体 1(LAT1,几率比 [95% 置信区间]:12.35 [2.93-52.0012.35 [2.93-52.05],P 结论:LAT1 的激活与胎盘功能有关:尽管控制了血糖,但在葡萄糖耐受不良妇女的胎盘中仍观察到 LAT1 和胎盘-FABPpm 表达的激活,这表明除血糖外,其他营养物质也应得到有效管理。
{"title":"Evaluation of expression of amino acid and fatty acid metabolic transporters in the placenta of pregnant women with glucose intolerance","authors":"Toshihide Sakuragi,&nbsp;Eiji Shibata,&nbsp;Megumi Yamamoto,&nbsp;Shohei Shimajiri,&nbsp;Emi Kondo,&nbsp;Hiroshi Mori,&nbsp;Ryosuke Tajiri,&nbsp;Toshiyuki Nakayama,&nbsp;Kiyoshi Yoshino,&nbsp;Mayumi Tsuji","doi":"10.1111/jog.16163","DOIUrl":"10.1111/jog.16163","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Pregnant women with glucose intolerance often have large infants, even with strict glycemic control. We examined the expression of amino and fatty acid metabolic transporters in the placentas of such mothers to clarify the role of factors other than glucose transport resulting in giant infants.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Deliveries at our hospital between 2017 and 2022 were assessed. Immunohistochemical staining of membrane transporters related to glucose, amino acid, and fatty acid transport was performed using postpartum placental tissue. Stained areas were classified and scored, and compared using the Mann–Whitney <i>U</i> test. Multiple logistic regression analysis was performed for large for gestational age infant as the outcome and maternal age, prepartum body mass index, primipara/multipara, gestational week, and glucose intolerance as confounding factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 1725 subjects, 101 met the inclusion criteria and were analyzed (glucose-intolerant [GI] group, <i>n</i> = 61; non-GI group, <i>n</i> = 40). Per unit villus, there was decreased expression of amino acid-related transporters. However, per unit placenta, the immunohistochemical staining scores for glucose, amino acid, and fatty acid transport were significantly higher in the GI than in the non-GI group. Multiple logistic regression analysis showed that L-type amino acid transporter 1 (LAT1, odds ratio [95% confidence interval]: 12.35 [2.93–52.05], <i>p</i> &lt; 0.001) and placenta-plasma membrane fatty acid-binding protein (placenta-FABPpm, 6.27 [1.64–23.88], <i>p</i> = 0.007) were significantly higher in the GI than in the non-GI group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Activation of LAT1 and placenta-FABPpm expressions observed in the placentas of glucose-intolerant women despite glycemic control indicate that nutrients other than blood glucose should also be effectively managed.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2021 and annual treatment report for 2016 日本妇产科学会妇科肿瘤委员会年度报告:2021 年度患者报告和 2016 年度治疗报告。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-25 DOI: 10.1111/jog.16168
Hiroaki Kajiyama, Satoshi Tamauchi, Fumiaki Takahashi, Kei Kawana, Board members of the 2023 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology

Aim

To provide information including the trend of gynecological malignancies in Japan, we hereby present the Annual Patient Report for 2021 and the Annual Treatment Report for 2016, on the outcomes of patients who started treatment in 2016.

Methods

The Japan Society of Obstetrics and Gynecology maintains an annual tumor registry, where information on gynecological malignancies from various participating institutions is gathered. The data of patients whose treatment with gynecologic malignancies was initiated in 2021 were analyzed retrospectively. Survival of the patients who started treatment with cervical, endometrial, and ovarian cancer in 2016 was analyzed by using the Kaplan–Meier, log-rank, and Wilcoxson tests.

Results

Treatment was initiated in 2021 for 8006 patients with cervical cancer, 13 912 with endometrial cancer, 8337 with ovarian, tubal, and peritoneal cancer, 2375 with ovarian borderline tumors, and with the others (226 vulvar cancer, 161 vaginal cancer, 437 uterine sarcoma, 47 uterine adenosarcoma, 160 trophoblastic diseases). This clinicopathological information was summarized as the Patient Annual Report. The 5-year survival rates of the patients with cervical cancer were 92.3%, 77.0%, 56.1%, and 30.3% for stages I, II, III, and IV, respectively. The 5-year survival rates for the patients with endometrial cancer were 94.1%, 88.8%, 71.2%, and 24.5% for stages I, II, III, and IV, respectively. The 5-year survival rates for the patients with ovarian cancer (surface epithelial-stromal tumors) were 91.3%, 78.8%, 54.3%, and 36.8% for stages I, II, III, and IV, respectively.

Conclusion

The annual tumor report is an important survey that provides knowledge on gynecological malignancy trends in Japan.

目的:为了提供包括日本妇科恶性肿瘤趋势在内的信息,我们特此提交 2021 年年度患者报告和 2016 年年度治疗报告,介绍 2016 年开始治疗的患者的治疗结果:日本妇产科学会每年都会进行肿瘤登记,收集各参与机构的妇科恶性肿瘤信息。我们对 2021 年开始接受妇科恶性肿瘤治疗的患者数据进行了回顾性分析。对2016年开始接受治疗的宫颈癌、子宫内膜癌和卵巢癌患者的生存率采用卡普兰-梅耶检验、对数秩检验和威尔科克森检验进行了分析:2021年开始治疗的宫颈癌患者有8006人,子宫内膜癌患者有13912人,卵巢癌、输卵管癌和腹膜癌患者有8337人,卵巢边缘瘤患者有2375人,其他患者(外阴癌226人,阴道癌161人,子宫肉瘤437人,子宫腺肉瘤47人,滋养细胞疾病160人)也是如此。这些临床病理信息汇总为《患者年度报告》。宫颈癌 I 期、II 期、III 期和 IV 期患者的 5 年生存率分别为 92.3%、77.0%、56.1% 和 30.3%。子宫内膜癌患者的 5 年生存率在 I、II、III 和 IV 期分别为 94.1%、88.8%、71.2% 和 24.5%。卵巢癌(表面上皮-间质肿瘤)患者的 5 年生存率在 I、II、III 和 IV 期分别为 91.3%、78.8%、54.3% 和 36.8%:肿瘤年报是一项重要的调查,它提供了有关日本妇科恶性肿瘤趋势的知识。
{"title":"Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2021 and annual treatment report for 2016","authors":"Hiroaki Kajiyama,&nbsp;Satoshi Tamauchi,&nbsp;Fumiaki Takahashi,&nbsp;Kei Kawana,&nbsp;Board members of the 2023 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology","doi":"10.1111/jog.16168","DOIUrl":"10.1111/jog.16168","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To provide information including the trend of gynecological malignancies in Japan, we hereby present the Annual Patient Report for 2021 and the Annual Treatment Report for 2016, on the outcomes of patients who started treatment in 2016.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The Japan Society of Obstetrics and Gynecology maintains an annual tumor registry, where information on gynecological malignancies from various participating institutions is gathered. The data of patients whose treatment with gynecologic malignancies was initiated in 2021 were analyzed retrospectively. Survival of the patients who started treatment with cervical, endometrial, and ovarian cancer in 2016 was analyzed by using the Kaplan–Meier, log-rank, and Wilcoxson tests.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Treatment was initiated in 2021 for 8006 patients with cervical cancer, 13 912 with endometrial cancer, 8337 with ovarian, tubal, and peritoneal cancer, 2375 with ovarian borderline tumors, and with the others (226 vulvar cancer, 161 vaginal cancer, 437 uterine sarcoma, 47 uterine adenosarcoma, 160 trophoblastic diseases). This clinicopathological information was summarized as the Patient Annual Report. The 5-year survival rates of the patients with cervical cancer were 92.3%, 77.0%, 56.1%, and 30.3% for stages I, II, III, and IV, respectively. The 5-year survival rates for the patients with endometrial cancer were 94.1%, 88.8%, 71.2%, and 24.5% for stages I, II, III, and IV, respectively. The 5-year survival rates for the patients with ovarian cancer (surface epithelial-stromal tumors) were 91.3%, 78.8%, 54.3%, and 36.8% for stages I, II, III, and IV, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The annual tumor report is an important survey that provides knowledge on gynecological malignancy trends in Japan.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to “Outstanding performance of ChatGPT on the obstetrics and gynecology board certification examination in Japan: Document and image-based questions analysis” 致 "ChatGPT 在日本妇产科医师资格考试中的出色表现 "的信:基于文件和图像的问题分析"。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-22 DOI: 10.1111/jog.16164
Shigeki Matsubara
{"title":"Letter to “Outstanding performance of ChatGPT on the obstetrics and gynecology board certification examination in Japan: Document and image-based questions analysis”","authors":"Shigeki Matsubara","doi":"10.1111/jog.16164","DOIUrl":"10.1111/jog.16164","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142687184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Japan Society of Obstetrics and Gynecology revised diagnostic criteria for polycystic ovary syndrome: JSOG2024 criteria 日本妇产科学会修订的多囊卵巢综合征诊断标准:JSOG2024 标准。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-21 DOI: 10.1111/jog.16152
Hiroki Noguchi, Akira Iwase, Takeshi Iwasa, Haruhiko Kanasaki, Fuminori Kimura, Koji Kugu, Kazuki Saito, Tsuyoshi Baba, Tetsuaki Hara, Saki Minato, Rie Yanagihara, Toshiya Matsuzaki, from the subcommittee “Validation of diagnostic criteria for polycystic ovary syndrome in Japan” in Reproductive Endocrine Committee, Japan Society of Obstetrics and Gynecology

Japanese patients with polycystic ovary syndrome (PCOS) exhibit distinct body type characteristics, such that the rate of overweight/obese women is remarkably low. In addition, hyperandrogenism is relatively rare among Japanese PCOS patients. Therefore, these factors are considered in PCOS diagnostic criteria used in Japan. Diagnostic criteria for PCOS were recently revised by the Japan Society of Obstetrics and Gynecology based on a nationwide survey of PCOS and released on December 5, 2023 (JSOG2024). JSOG2024 criteria diagnosed PCOS according to the following three items: (1) irregular menstrual cycle/chronic anovulation, (2) polycystic ovarian morphology or elevated serum anti-Müllerian hormone (AMH) level, and (3) hyperandrogenism or high luteinizing hormone. The presence of all three items is required to diagnose PCOS, after excluding other diseases with symptoms similar to PCOS. We also established AMH cut-off values by age and a system for evaluating ovarian findings useful for both the JSOG2024 and Rotterdam criteria. We anticipate that the JSOG2024 criteria with cut-off values will enhance the treatment of Japanese patients with PCOS and those of other ethnicities with low obesity and hirsutism.

日本的多囊卵巢综合征(PCOS)患者具有明显的体型特征,因此超重/肥胖妇女的比例非常低。此外,高雄激素症在日本多囊卵巢综合症患者中也相对罕见。因此,日本采用的多囊卵巢综合症诊断标准考虑了这些因素。日本妇产科学会最近根据一项全国性多囊卵巢综合征调查对多囊卵巢综合征的诊断标准进行了修订,并于 2023 年 12 月 5 日发布了修订版(JSOG2024)。JSOG2024 标准根据以下三项诊断多囊卵巢综合征:(1)月经周期不规则/慢性无排卵;(2)多囊卵巢形态或血清抗缪勒氏管激素(AMH)水平升高;(3)雄激素过高或黄体生成素过高。在排除症状与多囊卵巢综合症相似的其他疾病后,诊断多囊卵巢综合症需要同时具备这三个项目。我们还根据年龄确定了 AMH 临界值,并建立了一套对 JSOG2024 和鹿特丹标准都有用的卵巢检查结果评估系统。我们预计,JSOG2024 标准和分界值将会改善日本多囊卵巢综合症患者和其他种族低肥胖多毛患者的治疗。
{"title":"Japan Society of Obstetrics and Gynecology revised diagnostic criteria for polycystic ovary syndrome: JSOG2024 criteria","authors":"Hiroki Noguchi,&nbsp;Akira Iwase,&nbsp;Takeshi Iwasa,&nbsp;Haruhiko Kanasaki,&nbsp;Fuminori Kimura,&nbsp;Koji Kugu,&nbsp;Kazuki Saito,&nbsp;Tsuyoshi Baba,&nbsp;Tetsuaki Hara,&nbsp;Saki Minato,&nbsp;Rie Yanagihara,&nbsp;Toshiya Matsuzaki,&nbsp;from the subcommittee “Validation of diagnostic criteria for polycystic ovary syndrome in Japan” in Reproductive Endocrine Committee, Japan Society of Obstetrics and Gynecology","doi":"10.1111/jog.16152","DOIUrl":"10.1111/jog.16152","url":null,"abstract":"<p>Japanese patients with polycystic ovary syndrome (PCOS) exhibit distinct body type characteristics, such that the rate of overweight/obese women is remarkably low. In addition, hyperandrogenism is relatively rare among Japanese PCOS patients. Therefore, these factors are considered in PCOS diagnostic criteria used in Japan. Diagnostic criteria for PCOS were recently revised by the Japan Society of Obstetrics and Gynecology based on a nationwide survey of PCOS and released on December 5, 2023 (JSOG2024). JSOG2024 criteria diagnosed PCOS according to the following three items: (1) irregular menstrual cycle/chronic anovulation, (2) polycystic ovarian morphology or elevated serum anti-Müllerian hormone (AMH) level, and (3) hyperandrogenism or high luteinizing hormone. The presence of all three items is required to diagnose PCOS, after excluding other diseases with symptoms similar to PCOS. We also established AMH cut-off values by age and a system for evaluating ovarian findings useful for both the JSOG2024 and Rotterdam criteria. We anticipate that the JSOG2024 criteria with cut-off values will enhance the treatment of Japanese patients with PCOS and those of other ethnicities with low obesity and hirsutism.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causes and clinical characteristics of women with primary amenorrhea and ovarian or gonadal disorders at a quaternary hospital 一家四级医院中患有原发性闭经和卵巢或性腺疾病的妇女的病因和临床特征。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-21 DOI: 10.1111/jog.16165
Krantarat Peeyananjarassri, Satit Klangsin, Apisada Chumkam, Saranya Wattanakumtornkul, Kriengsak Dhanaworavibul, Chainarong Choksuchat, Chatpavit Getpook, Phawat Matemanosak, Chariyawan Charalsawadi, Worathai Maisrikhaww

Aim

To evaluate the causes and clinical characteristics of primary amenorrhea and ovarian or gonadal disorders in women.

Methods

The medical records of all women evaluated for primary amenorrhea between January 2002 and December 2023 were retrospectively reviewed. Women with missing data were excluded from the study. Disorders of the ovary or gonads (hypergonadotropic hypogonadism) were defined as increased serum follicle-stimulating hormone (FSH) levels (>40 mIU/mL).

Results

Over a 21-year period, after excluding 1 woman with incomplete data, the study included 87 women who met the inclusion criteria. The median age at presentation was 18 years (interquartile range [IQR], 17–20). The median estradiol level was 5 pg/mL (IQR 5–10.4), and the median FSH level was 80 mIU/mL (IQR 63.1–94.9). The most common cause of primary amenorrhea was Turner syndrome (TS), followed by 46,XX and 46,XY gonadal dysgenesis. The median height was 147 cm (IQR, 140–158.7), and 50 women (57.5%) had karyotypic abnormalities, with TS being the most common abnormality.

Conclusion

TS was identified as the most common cause of primary amenorrhea with ovarian or gonadal disorders.

目的:评估女性原发性闭经和卵巢或性腺疾病的原因和临床特征:方法:回顾性审查 2002 年 1 月至 2023 年 12 月期间所有接受原发性闭经评估的女性的病历。研究排除了数据缺失的女性。卵巢或性腺疾病(促性腺功能减退症)定义为血清卵泡刺激素(FSH)水平升高(>40 mIU/mL):在 21 年的时间里,在排除了 1 名数据不完整的女性后,该研究共纳入了 87 名符合纳入标准的女性。发病时的中位年龄为 18 岁(四分位数间距 [IQR],17-20 岁)。雌二醇水平中位数为 5 pg/mL(IQR 5-10.4),FSH 水平中位数为 80 mIU/mL(IQR 63.1-94.9)。原发性闭经最常见的原因是特纳综合征(TS),其次是 46,XX 和 46,XY 性腺发育不良。身高中位数为 147 厘米(IQR,140-158.7),50 名女性(57.5%)有核型异常,其中 TS 是最常见的异常:结论:TS 是原发性闭经伴有卵巢或性腺疾病的最常见原因。
{"title":"Causes and clinical characteristics of women with primary amenorrhea and ovarian or gonadal disorders at a quaternary hospital","authors":"Krantarat Peeyananjarassri,&nbsp;Satit Klangsin,&nbsp;Apisada Chumkam,&nbsp;Saranya Wattanakumtornkul,&nbsp;Kriengsak Dhanaworavibul,&nbsp;Chainarong Choksuchat,&nbsp;Chatpavit Getpook,&nbsp;Phawat Matemanosak,&nbsp;Chariyawan Charalsawadi,&nbsp;Worathai Maisrikhaww","doi":"10.1111/jog.16165","DOIUrl":"10.1111/jog.16165","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To evaluate the causes and clinical characteristics of primary amenorrhea and ovarian or gonadal disorders in women.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The medical records of all women evaluated for primary amenorrhea between January 2002 and December 2023 were retrospectively reviewed. Women with missing data were excluded from the study. Disorders of the ovary or gonads (hypergonadotropic hypogonadism) were defined as increased serum follicle-stimulating hormone (FSH) levels (&gt;40 mIU/mL).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Over a 21-year period, after excluding 1 woman with incomplete data, the study included 87 women who met the inclusion criteria. The median age at presentation was 18 years (interquartile range [IQR], 17–20). The median estradiol level was 5 pg/mL (IQR 5–10.4), and the median FSH level was 80 mIU/mL (IQR 63.1–94.9). The most common cause of primary amenorrhea was Turner syndrome (TS), followed by 46,XX and 46,XY gonadal dysgenesis. The median height was 147 cm (IQR, 140–158.7), and 50 women (57.5%) had karyotypic abnormalities, with TS being the most common abnormality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>TS was identified as the most common cause of primary amenorrhea with ovarian or gonadal disorders.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring potential pathways from oxidative stress to ovarian aging 探索从氧化应激到卵巢衰老的潜在途径。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-21 DOI: 10.1111/jog.16166
Hiroshi Kobayashi, Shogo Imanaka

Aim

In developed nations, women have increasingly deferred childbearing, leading to a rise in demand for infertility treatments and the widespread use of assisted reproductive technologies. However, despite advancements in in vitro fertilization (IVF), live birth rates among women over 40 remain suboptimal. Mitochondrial dysfunction is widely recognized as a key factor in the processes driving the age-related deterioration in both the quantity and quality of oocytes. We aim to summarize current insights into ovarian aging, with a particular focus on pathways that impair mitochondrial function, and explore directions for future research.

Methods

Electronic databases were searched for articles published up to June 30, 2024.

Results

Ongoing ovulation, luteolysis, and menstruation trigger exogenous reactive oxygen species (ROS)-mediated oxidative stress that damages mitochondrial DNA. This, in turn, reduces nuclear gene expression, compromises mitochondrial oxidative phosphorylation, and diminishes adenosine 5′ triphosphate production. Persistent endogenous ROS further exacerbate mitochondrial DNA damage and aneuploidy, ultimately causing irreversible chromosomal abnormalities, leading to oocyte aging.

Conclusions

We have delineated the pathway from oxidative stress to ovarian aging. Early detection and management of ovarian aging present challenges and opportunities to enhance IVF treatment strategies.

目的:在发达国家,越来越多的妇女推迟生育,导致对不孕不育治疗需求的增加和辅助生殖技术的广泛使用。然而,尽管体外受精(IVF)技术不断进步,40 岁以上妇女的活产率仍然不理想。线粒体功能障碍被广泛认为是卵母细胞数量和质量随年龄增长而下降的关键因素。我们旨在总结目前对卵巢衰老的认识,尤其关注损害线粒体功能的途径,并探讨未来的研究方向:方法:检索电子数据库中截至 2024 年 6 月 30 日发表的文章:持续的排卵、黄体溶解和月经会引发外源性活性氧(ROS)介导的氧化应激,从而损伤线粒体DNA。这反过来又会降低核基因表达,损害线粒体氧化磷酸化,减少 5'三磷酸腺苷的产生。持续的内源性 ROS 会进一步加剧线粒体 DNA 损伤和非整倍体,最终造成不可逆的染色体异常,导致卵母细胞衰老:我们已经描述了从氧化应激到卵巢衰老的途径。卵巢衰老的早期检测和管理为改进试管婴儿治疗策略带来了挑战和机遇。
{"title":"Exploring potential pathways from oxidative stress to ovarian aging","authors":"Hiroshi Kobayashi,&nbsp;Shogo Imanaka","doi":"10.1111/jog.16166","DOIUrl":"10.1111/jog.16166","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>In developed nations, women have increasingly deferred childbearing, leading to a rise in demand for infertility treatments and the widespread use of assisted reproductive technologies. However, despite advancements in in vitro fertilization (IVF), live birth rates among women over 40 remain suboptimal. Mitochondrial dysfunction is widely recognized as a key factor in the processes driving the age-related deterioration in both the quantity and quality of oocytes. We aim to summarize current insights into ovarian aging, with a particular focus on pathways that impair mitochondrial function, and explore directions for future research.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Electronic databases were searched for articles published up to June 30, 2024.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Ongoing ovulation, luteolysis, and menstruation trigger exogenous reactive oxygen species (ROS)-mediated oxidative stress that damages mitochondrial DNA. This, in turn, reduces nuclear gene expression, compromises mitochondrial oxidative phosphorylation, and diminishes adenosine 5′ triphosphate production. Persistent endogenous ROS further exacerbate mitochondrial DNA damage and aneuploidy, ultimately causing irreversible chromosomal abnormalities, leading to oocyte aging.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>We have delineated the pathway from oxidative stress to ovarian aging. Early detection and management of ovarian aging present challenges and opportunities to enhance IVF treatment strategies.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142687260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Obstetrics and Gynaecology Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1